Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 may prevent hair loss caused by chemotherapy.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

The compound 4c showed strong potential as an anticancer agent.

Increasing PDCD4 protein may help prevent or treat some skin cancers.

K6/ODC transgenic mice are effective for quickly identifying cancer-causing chemicals.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

The treatment was ineffective in humans.

Early sunburn treatment with certain inhibitors may reduce skin cancer risk.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

Certain substances can strongly inhibit DNA synthesis in hair cells.

Polyamines are crucial for skin tumor development, and inhibiting them can prevent tumors.

Mice with extra PKCδ resist chemical-induced skin cancer but not UV-induced.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Tadalafil and Finasteride may help treat aggressive melanoma.